Applonia Rose

Applonia Rose, PhD, currently serves as Managing Editor at Sage since May 2021, overseeing the Technology in Cancer Research & Treatment journal with an impact factor of 2.8. Since May 2016, Applonia has also been a Commissioning Editor at BioInsights, focusing on content development, peer review management, and quality assurance. Prior experience includes working as a Review Commissioner at Dove Medical Press from August 2014 to 2016, where Applonia commissioned review articles for various reputable journals. Applonia's academic background includes a PhD in Biomedical Sciences from KU Leuven, where the doctoral thesis focused on cell biology and molecular genetics, as well as a predoctorate degree in the same field. Additional educational qualifications include a Short Course on Drug Regulatory Affairs from King's College London and a Master of Science in Biotechnology from Kannur University. Applonia holds a Bachelor of Science in Microbiology from St. Pius X College.